An underground economy for unapproved weight-loss drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, according to recent findings.
Investigational Drug Gaining Popularity Online
Retatrutide, which remains in clinical trials, is being advertised by online personalities for its supposed fat-burning effects. Followers are encouraged to contact these profiles privately for supplier links, while also obtaining promotional offers.
Active Trade on Social Networks
Separately, a flourishing trade exists on messaging services, where groups with numerous of participants share “before and after” images, injection guides and claims of next-day UK delivery. Vendors market the drug there before redirecting customers to other platforms for transactions.
Understanding The Experimental Drug
Retatrutide is an investigational injection created by US drugmaker Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials indicate it could assist individuals reduce up to 25% of their body weight. Referred to as the “triple G”, the drug is being hailed digitally as the successor to Ozempic.
Healthcare Professionals Express Concerns
However, doctors and chemists have cautions that the distribution of what remains an unapproved medication in the United Kingdom is a cause for concern and could lead to individuals injecting substances of unknown origin.
Some experts said the popularity for retatrutide could be linked to the increasing price of licensed slimming products such as Mounjaro.
Regulatory Position and Implementation
Marketing retatrutide on social media or Telegram is illegal in the United Kingdom, as it is an unapproved drug that must not be marketed or supplied for human use under the Human Medicines Regulations 2012.
Several influencers attempt to circumvent the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but advertising and distribution can still violate medicines, marketing, and consumer regulations, risking fines, legal action or imprisonment.
Platform Reaction and Content Elimination
Based on TikTok, the platform has removed violative material and prohibited related hashtags and search suggestions. The organization said it was committed to keeping the service safe and allocating resources in strengthening compliance measures.
Online Trading Activities
Research also found communities with up to nine thousand members marketing the experimental drug using the platform's built-in search feature, which functions like a public directory. Entering “retatrutide” immediately brings up groups with numerous of users, populated with photos of weight loss, positive reviews and detailed instructions for mixing or injecting at residence.
Within moments of joining one group, a vendor posted contact information, where most transactions occur. The vendor sent an instruction manual and promised shipping within two days. When asked whether the substance was genuine, one seller responded: “You can’t be sure.” Another shared a photo of a supposed testing documentation. Not one asked about weight, health issues or previous experience.
Product Information and Pricing
Inside these groups, messages show dark colored packages with Royal Mail stickers, stating to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Buyers can choose between powder vials, mixed at residence with purified liquid, or ready-to-use injectors typically sold at £160 for 20mg. When asked how long a pen should be used, sellers give contradictory responses varying between a few weeks to “depends on your body”.
Service Moderation and Safety Measures
A spokesperson for Telegram stated it regularly monitored dangerous content on its service including material that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Healthcare Professional Warnings
“People are administering materials they can’t verify. Even if the research behind this drug is valid, these online versions may not include what they claim,” said a pharmacy expert, the director of pharmaceutical services at Chemist4U.
A medical professional of Asda Online Doctor connected the increase in demand to recent cost increases for approved weight-loss drugs such as Mounjaro. “With prices rising, patients are using social media. But counterfeit treatments are highly risky. You can’t be certain what’s contained or whether the environment they were made in was clean,” she said.
Her team has already encountered individuals harmed by self-injection from unverified suppliers. “We understand the disappointment, but buying from Telegram or communication platforms is gambling with your health,” stated the doctor. “These substances could be contaminated or improperly measured.”
Producer Statement
A spokesperson from the pharmaceutical company stated the substance was in third stage clinical trials and had not been evaluated or approved by any regulatory agency globally. “Therefore at this time no one can sell [it] for personal consumption,” they explained, noting that any item “falsely representing itself as a company investigational substance not yet approved … may subject patients to possibly significant health risks”.
